| |
|
|
|
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
April 7 - 10, 2011
The first meeting on Stem Cell Engineering and Cell-Based Therapies will take place at Cold Spring Harbor Laboratory, from April 7 (7:30 pm) to April 10, 2011 (12:00 pm). The recent availability of human pluripotent stem cells and progress in the genetic engineering of these stem cells, somatic stem cells, and their progeny creates new prospects for advancing cell-based therapies. This meeting will focus on emerging paradigms in cellular reprogramming, directed differentiation and therapeutic cell engineering. Its purpose is to foster scientific exchange and discussion of current challenges to the generation of progenitor and differentiated cell types that are safe and suitable for transplantation, as well as strategies to achieve high fidelity genetic engineering. The ultimate goal of these discussions is to identify and evaluate promising paths for clinical translation of emerging cell-based therapies. Individual sessions will focus on current and developing “hot topics”, including advances and obstacles to directed differentiation in mesodermal, endodermal or neuroectodermal cell types, targeted gene delivery, immune engineering, barriers to effective cell transplantation and graft acceptance, and other relevant themes.
|
|
|
|
|
|
|
|
Organized by:
|
|
Rudolf Jaenisch, Michel Sadelain, Amy Wagers |
|
|
Invited Speakers:
|
|
Keynote Speaker:
Irving Weissman, Stanford University School of Medicine
Topics:
Fundamental issues in hpPS/hES cell differentiation
Hepatocytes and beta cells
Genetic Engineering of Stem Cells
Immune Engineering
Mesodermal Lineages
Neuroectodermal Lineages Invited Speakers:
Patrick Aubourg, INSERM
D. Balasubramanian, L.V. Prasad Eye Institute
Kenneth Chien, MGH
Fred Rusty Gage, The Salk Institute
Markus Grompe, Oregon Health Sciences University
Jacob Hanna, Whitehead Institute
Harry Heimberg, University of Brussels
Konrad Hochedlinger, MGH
Carl June, University of Pennsylvania
Gordon Keller, McEwen Centre for Regenerative Medicine
Eirini Papapetro, Memorial Sloan Kettering
Matthew Porteus, Stanford University
Deepak Srivastava, University of Califorinia, San Francisco
Lorenz Studer, MSKCC
Inder Verma, The Salk Institute
Juan Carlos Zuniga-Pflucker, University of Toronto
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
January 21, 2011
|
|
|
|
|
|
|
|
Registration:
|
|
https://meetings.cshl.edu/meetingR/Default.aspx
|
|
|
E-mail:
|
|
meetings@cshl.edu
|
|
|
|
|
|
|
|
|